4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001384243-26-000008
Director sold 6,901 shares at $50.00 ($345,050)
- Director acquired 6,901 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Quart Barry D · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,901 | $14.33 | $98,891 | 19,447 | D |
| 2026-04-06 | Sale : show line 2 in the form 10b5-1 | −6,901 | $50.00 | $345,050 | 12,546 | D |
| Open-market sales · 6,901 sh · avg $50.00 · $345,050 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-06 | Exercise or conversion : show line 3 in the form 10b5-1 Share Option | −6,901 | 26,336 | D |
Loading xslF345X06/form4-04082026_080443.xml…